The proinflammatory cytokine interleukin-1 (IL-1) induces several behavioral alterations that are characteristic of illness, such as anorexia and reduced locomotor and social activity. We have recently demonstrated that IL-1 inhibits sexual activity, motivation and attractivity in female, but not in male rats following either central or peripheral administration. In the present study we examined the involvement of prostaglandin (PG) synthesis in mediating IL-1-induced suppression of female sexual behavior. Administration of the cyclooxygenase blockers indomethacin or ibuprofen completely prevented IL-1-induced suppression of female sexual behavior, including the reduction in proceptive behavior, the lordosis response to a male's mounts, and the preference for a sexually active partner. In a subsequent study, ex-vivo release of hypothalamic PGE 2 and the secretion of corticosterone (CS) were measured in males and estrous females following IL-1 administration. At the same time and dose of IL-1 administration that significantly reduced sexual behavior in female but not male rats, IL-1 produced a significant increase in PGE 2 release in female, but not in male rats. In contrast, IL-1 induced a significant elevation of serum CS levels in males but not in females. These findings suggest that PG synthesis is involved in mediating the effects of IL-1 on female sexual behavior. Furthermore, differential secretion of PGs and CS may underlie the gender difference in the effects of IL-1 on sexual behavior.
INTRODUCTION
Interleukin-1 (IL-1), a proinflammatory cytokine, is released by activated macrophages during the acute phase of the immune response and mediates many of the host's reactions to infection and injury (Dinarello, 1996) . IL-1 is also involved in mediating the behavioral changes that accompany illness and that were collectively termed ''sickness behavior.'' (Hart, 1988; Kent, Bluth'e, Kelley, & Dantzer, 1992; Yirmiya, 1997) . Administration of IL-1 induces anorexia and reduced drinking (Otterness, Golden, Seymour, Eskra, & Daumy, 1991), hypersomnia (Krueger, Takahashi, Kapas, Bredow, Roky, Fang, Floyd, Renegar, Guth-Thakurata, Novitsky, & Obal, 1995) , suppressed activity and social exploration (Dantzer, Bluth'e, Aubert, Goodall, Bret-Dibat, Kent, Goujon, Lay'e, Parnet, & Kelley, 1996) , and altered pain sensitivity (Watkins, Maier, & Goehler, 1995) . We have recently demonstrated that IL-1 also inhibited sexual activity, motivation, and attractivity in female rats, following either central or peripheral administration. However, in males none of these behavioral parameters were affected by IL-1. This gender difference in the effects of IL-1 is specific to sexually related responses, since other behaviors, such as locomotion, were equally affected by IL-1 in both sexes (Avitsur, Donchin, Barak, Cohen, & Yirmiya, 1995; Avitsur, Pollak, & Yirmiya, 1997; Avitsur, Cohen, & Yirmiya, 1998; Yirmiya, Avitsur, Donchin, & Cohen 1995) . IL-1 was also found to potentiate the
